Radiology with AI: mediaire secures €12 million

Paris / Berlin — Gene­ra­tive AI is often still in its infancy. AI in radio­logy is anything but a vision of the future. The prac­ti­cal bene­fits of mediaire’s AI tech­no­logy can alre­ady be seen in over 350 hospi­tals and radio­logy prac­ti­ces across Europe. The Berlin-based start-up’s AI port­fo­lio is funda­men­tally chan­ging the way radio­lo­gists work. With this success, medi­aire has now secu­red a Euro­pean finan­cing round of €12 million, led by LBO France as lead inves­tor with the parti­ci­pa­tion of IBB Ventures and the Swiss family office Wille Finance. The finan­cing under­lines the importance of viable and vali­da­ted AI solu­ti­ons for clini­cal prac­tice. Previous medi­aire inves­tors HTGF, LIFTT and Gate­way Ventures also parti­ci­pa­ted in the over­sub­scri­bed round. mediaire’s AI solu­ti­ons are seam­lessly inte­gra­ted into diagno­stic prac­tice, reli­e­ving radio­lo­gists of routine tasks and impro­ving diagno­stic outco­mes for pati­ents. Thanks to the latest finan­cing round, medi­aire will expand its AI port­fo­lio in magne­tic reso­nance imaging (MRI) beyond the current areas of appli­ca­tion in AI-supported radio­lo­gi­cal brain, prostate and knee diagno­stics. With this next inno­va­tion step, further AI solu­ti­ons can be deve­lo­ped to enable grea­ter diagno­stic precis­ion and effi­ci­ency world­wide in the future. The finan­cing ther­e­fore repres­ents an important mile­stone for the company’s growth. “Our AI solu­ti­ons are not a dream of the future. We have alre­ady crea­ted a reality that helps doctors make infor­med decis­i­ons and provide their pati­ents with faster answers,” empha­si­zes Dr. Andreas Lemke, CEO and co-foun­­der of medi­aire. “We see the posi­tive impact every day with thou­sands of radio­lo­gists, in hundreds of hospi­tals and radio­logy prac­ti­ces across Europe where our AI soft­ware is alre­ady in use. With this invest­ment, we will bring these bene­fits to many more health­care provi­ders.” “We are convin­ced that tech­no­logy can improve lives,” adds Matthes Seeling, Invest­ment Direc­tor at LBO France. “mediaire’s focus reflects our strong belief in the trans­for­ma­tive power of health­care tech­no­logy for the bene­fit of profes­sio­nals and pati­ents. The dedi­ca­ted team addres­ses a pres­sing need in the health­care sector, parti­cu­larly in the context of incre­asing global demand for fast, accu­rate and afforda­ble diagno­stics. With this invest­ment, we will actively support mediaire’s growth to achieve its ambi­tious goals and conso­li­date its posi­tion as the leading provi­der of radio­logy AI in Europe.” Dr. Ange­lika Vlachou, Part­ner at HTGF, said: “We at HTGF are very plea­sed with the deve­lo­p­ment of medi­aire over the last years and believe that the team has proven the added value for its custo­mers, the radio­lo­gists. The field of AI-based tools is evol­ving rapidly. To be successful, compa­nies need to demons­trate real product inno­va­tion that is tail­o­red to the needs of custo­mers. We look forward to conti­nuing to support the deve­lo­p­ment of mediaire.”